000058468 001__ 58468
000058468 005__ 20200221144318.0
000058468 0247_ $$2doi$$a10.1007/s12094-016-1577-y
000058468 0248_ $$2sideral$$a97534
000058468 037__ $$aART-2016-97534
000058468 041__ $$aeng
000058468 100__ $$aMartin-Richard, M.
000058468 245__ $$aSEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
000058468 260__ $$c2016
000058468 5060_ $$aAccess copy available to the general public$$fUnrestricted
000058468 5203_ $$aEsophageal cancer (EC) is an aggressive tumor that represents the 6th most common cause of cancer death worldwide. The estimated incidence in Spain is 2090 cases/year. Two main pathological subtypes exist, squamous cell carcinoma and adenocarcinoma. The main differences between them are localization and underlying factors which are the principal cause of the recent incidence changes observed in west countries. Staging techniques and treatment options which combine surgery, chemotherapy and radiotherapy, reflected the high complexity of the EC management. An undeniably multidisciplinary approach is, therefore, required. In this guide, we review the status of current diagnosis and treatment, define evidence and propose recommendations.
000058468 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000058468 590__ $$a2.353$$b2016
000058468 591__ $$aONCOLOGY$$b141 / 217 = 0.65$$c2016$$dQ3$$eT2
000058468 592__ $$a0.774$$b2016
000058468 593__ $$aMedicine (miscellaneous)$$c2016$$dQ2
000058468 593__ $$aOncology$$c2016$$dQ2
000058468 593__ $$aCancer Research$$c2016$$dQ3
000058468 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000058468 700__ $$aDíaz Beveridge, R.
000058468 700__ $$aArrazubi, V.
000058468 700__ $$aAlsina, M.
000058468 700__ $$aGalan Guzmán, M.
000058468 700__ $$aCustodio, A.B.
000058468 700__ $$aGómez, C.
000058468 700__ $$aMuñoz, F.L.
000058468 700__ $$0(orcid)0000-0002-8026-7391$$aPazo, R.
000058468 700__ $$aRivera, F.
000058468 773__ $$g18, 12 (2016), 1179-1186$$pClin. transl. oncol.$$tClinical and Translational Oncology$$x1699-048X
000058468 8564_ $$s381141$$uhttps://zaguan.unizar.es/record/58468/files/texto_completo.pdf$$yVersión publicada
000058468 8564_ $$s92552$$uhttps://zaguan.unizar.es/record/58468/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000058468 909CO $$ooai:zaguan.unizar.es:58468$$particulos$$pdriver
000058468 951__ $$a2020-02-21-13:40:21
000058468 980__ $$aARTICLE